PDT Partners’s Precigen PGEN Stock Holding History

PDT Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-33,684	Closed	-$125K	–	1064
2021 Q4	$125K	Buy	+33,684	New	+$145K	0.01%	803
2015 Q3	–	Sell	-67,129	Closed	-$3.25M	–	1491
2015 Q2	$3.25M	Buy	+67,129	New	+$2.83M	0.08%	288
2014 Q4	–	Sell	-42,622	Closed	-$757K	–	976
2014 Q3	$757K	Buy	+42,622	New	+$870K	0.02%	801
2014 Q2	–	Sell	-9,324	Closed	-$234K	–	1574
2014 Q1	$234K	Buy	+9,324	New	+$258K	0.01%	1193

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PDT Partners's PGEN Position: Q1 2022 in Review

PDT Partners sold out of Precigen (PGEN) in Q1 2022, closing a stake of 33,684 shares — an estimated $125K sold.

PDT Partners first reported a position in PGEN in Q1 2014 and held it in 4 quarters. The position peaked at $3.25M in Q2 2015. 173 funds tracked by Wall St. Rank hold PGEN as of Q1 2022.

PDT Partners reported no remaining Precigen position as of Q1 2022 after selling out during the quarter.
PDT Partners sold 33,684 Precigen shares in Q1 2022, an estimated $125K.
PDT Partners first reported a position in Precigen in Q1 2014 and held it in 4 quarters.
PDT Partners's Precigen position peaked at $3.25M in Q2 2015.
173 funds tracked by Wall St. Rank held Precigen as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.